A systematic epidemiological trends analysis study in global burden of multiple myeloma and 29 years forecast
Authors:
Top Cited Papers
Open Access
- 16 January 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Abstract
Multiple myeloma is a prevalent hematologic cancer. This investigation analyzes the latest global, regional, and national data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021. Data on the incidence, prevalence, disability-adjusted life years, and mortality rates of multiple myeloma, including estimates and 95% uncertainty intervals, were sourced from the 2021 Global Burden of Diseases Study. Furthermore, we explored the trends affecting the multiple myeloma burden from 1990 to 2021, breaking it down by demographic, age, and epidemiological factors. By 2021, the global incidence of multiple myeloma involved 148,754.63 reported cases, with confidence intervals ranging from 131,780.43 to 162,049.23. Worldwide, the number of mortality attributed to multiple myeloma reached 116,359.63, with the confidence interval lying between 103,078.62 and 128,470.57, and an age-standardized mortality rate of 1.37 per 100,000 individuals, the confidence interval for which was 1.22 to 1.52. There was a consistent increase in the incidence, prevalence, and disability-adjusted life years associated with multiple myeloma. Most of the disease burdens were seen in high income countries though its incidence is on the rise in low-income countries. Forecast for the years 2022–2050 showed the further increase in the incidence, prevalence, disability-adjusted life years, and age-standardized death rates of multiple myeloma.Keywords
All Related Versions
Funding Information
- Applied Basic Research Program of Science and Technology Department of Liaoning Province (2023JH2/101300036)
This publication has 28 references indexed in Scilit:
- Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and managementAmerican Journal of Hematology, 2024
- Trends and cross-country inequalities in the global burden of osteoarthritis, 1990–2019: A population-based studyAgeing Research Reviews, 2024
- Disparities in Multiple Myeloma Treatment Patterns in the United States: A Systematic ReviewClinical Lymphoma Myeloma and Leukemia, 2023
- Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019Autoimmunity Reviews, 2023
- Diagnosis and Management of Multiple MyelomaJAMA, 2022
- Leveraging RSF and PET images for prognosis of multiple myeloma at diagnosisInternational Journal of Computer Assisted Radiology and Surgery, 2019
- Global Burden of Multiple MyelomaJAMA Oncology, 2018
- The Non-uniqueness Property of the Intrinsic Estimator in APC ModelsDemography, 2014
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Assessing Validity and Application Scope of the Intrinsic Estimator Approach to the Age-Period-Cohort ProblemDemography, 2013